PhRMA: 88 Medicines & Vaccines in Development for HIV/AIDS

Of the 88 medicines and vaccines in development, 49 are antivirals and 27 are vaccines. All of the medicines are either in clinical trials or awaiting review by the FDA.

America's biopharmaceutical research companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

While HIV/AIDS is one of the most devastating diseases affecting people around the world, overall global growth of the disease has stabilized, the number of new infections has been steadily declining, and there are fewer AIDS-related deaths due to the availability of different therapies, such as antiretrovirals, and an enhanced focus on prevention.

Over the past three decades, more than 30 medicines have been approved to treat HIV/AIDS. While these medicines have helped to prolong the lives of HIV-infected patients, it is not enough. America's biopharmace